Chronic Cannabis Use in the Compassionate Investigational New Drug Program posted on February 18, 2020 …Continue Reading about Chronic Cannabis Use in the Compassionate Investigational New Drug Program →
Synthetic and natural cannabinoids: the cardiovascular risk posted on February 18, 2020 …Continue Reading about Synthetic and natural cannabinoids: the cardiovascular risk →
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues posted on February 18, 2020 …Continue Reading about Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues →
Clinical Endocannabinoid Deficiency Reconsidered posted on February 18, 2020 …Continue Reading about Clinical Endocannabinoid Deficiency Reconsidered →
Clinical Endocannabinoid Deficiency (CECD) posted on February 18, 2020 …Continue Reading about Clinical Endocannabinoid Deficiency (CECD) →
Cannabis Therapeutics and the Future of Neurology posted on February 18, 2020 …Continue Reading about Cannabis Therapeutics and the Future of Neurology →